2/🚨 Our topic🚨: A Comprehensive Framework for Kidney Function Assessment: Summary of the NIDDKD Reimagining Kidney Function Assessment Workshop.
There are no conflicts of interest. #MedSky#NephSky#MedTwitter#nephtwitter@ISNkidneycare
Article 👉https://t.co/zoAlV8jV7t. .
CKD causes significant morbidity & mortality among children w/heart failure. Read this Original Article on heart-kidney transplant outcomes compared to heart-only transplants in children w/non-dialysis-dependent advanced CKD.
https://t.co/qoDY5yEj4U
🧵 New #Tweetorial Drop! 🧵
1/ Hey #NephTwitter! 👋
We’re back with a fresh #XTorial from @KIReports, this time diving into:
Dapagliflozin in Stage 4 CKD: no diabetes required? 🤔
Let’s unpack what this trial means for your next CKD patient. 💊💭
Thoughts about Wegovy vs Zepbound for MACE Reduction? #MedTwitter#NephTwitter
Finding:
-Semaglutide showed 29% reduction
Limits:
-Small # of MACE
-Retrospective
Implications:
-Wegovy may be better for those with ASCVD
-Does GIP have any CV benefits?
https://t.co/LLZ5cKUk1K
❗Don't miss out!
This month: IPNA Journal Club📖 - IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis
🌟👉Free registration: https://t.co/qXDOUb6kHf
See you on Jan 16!
#pedneph#learning
Another @KIReports community blog. This time from me! This one is rather personal, as a physician with T1D (30 years in May 2025), I’ve fell a bit left out of all of the advances in diabetic nephropathy. Read more #NephTwitter#MedTwitter
https://t.co/tWoc7zziiL
@captainchloride Thanks for sharing! I have been following you a lot peripherally. Curious if you mind sharing the study? Want to see who was in the study that came with this equation as I see some adolescents with Fontans and fluid overload